Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco A Mauri

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Clinical Pathology|October 23, 2012
CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinomaDavid J Pinato, Paul Nya, Rohini Sharma, et al.
Future Oncology (London, England)|August 12, 2009
Trastuzumab: unusual responses and toxicitiesEliyaz Ahamed, Francesco A Mauri, Grant Pakter, et al.
Journal of Clinical Pathology|November 4, 2017
PD-L1Anthousa Kythreotou, Abdul Siddique, Francesco A Mauri, et al.
Oncology Reports|May 23, 2012
Isogeneic comparison of primary and metastatic lung cancer identifies CX3CR1 as a molecular determinant of site-specific metastatic diffusionFrancesco A Mauri, David J Pinato, Pritesh Trivedi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Inflammation-based prognostic indices in malignant pleural mesotheliomaDavid James Pinato, Francesco A Mauri, Rathi Ramakrishnan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2010
Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancerTony Dhillon, Francesco A Mauri, Guido Bellezza, et al.
Oncoimmunology|November 18, 2017
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behaviorDavid J Pinato, James R Black, Sebastian Trousil, et al.
International Journal of Oncology|September 30, 2010
Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosaGraziella Bellone, Claudia Gramigni, Barbara Vizio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 14, 2015
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinomaCarlo Smirne, Glenda Grossi, David J Pinato, et al.
British Journal of Cancer|February 16, 2019
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinomaDavid J Pinato, Matthew W Brown, Sebastian Trousil, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Clinical Pathology|October 23, 2012
CD24: a potential new marker in differentiating malignant mesothelioma from pulmonary adenocarcinomaDavid J Pinato, Paul Nya, Rohini Sharma, et al.
Future Oncology (London, England)|August 12, 2009
Trastuzumab: unusual responses and toxicitiesEliyaz Ahamed, Francesco A Mauri, Grant Pakter, et al.
Journal of Clinical Pathology|November 4, 2017
PD-L1Anthousa Kythreotou, Abdul Siddique, Francesco A Mauri, et al.
Oncology Reports|May 23, 2012
Isogeneic comparison of primary and metastatic lung cancer identifies CX3CR1 as a molecular determinant of site-specific metastatic diffusionFrancesco A Mauri, David J Pinato, Pritesh Trivedi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 7, 2012
Inflammation-based prognostic indices in malignant pleural mesotheliomaDavid James Pinato, Francesco A Mauri, Rathi Ramakrishnan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 23, 2010
Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancerTony Dhillon, Francesco A Mauri, Guido Bellezza, et al.
Oncoimmunology|November 18, 2017
Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behaviorDavid J Pinato, James R Black, Sebastian Trousil, et al.
International Journal of Oncology|September 30, 2010
Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosaGraziella Bellone, Claudia Gramigni, Barbara Vizio, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 14, 2015
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinomaCarlo Smirne, Glenda Grossi, David J Pinato, et al.
British Journal of Cancer|February 16, 2019
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinomaDavid J Pinato, Matthew W Brown, Sebastian Trousil, et al.
Pageof 3